Results 11 to 20 of about 1,703,276 (117)

Flood Modeling on Koya Catchment Area Using Hyfran, Web Map Service, and HEC-RAS Software [PDF]

, 2021
In this research, The boundaries of the Koya catchment area have been delineated, and valley paths in the region were drawn by using the Water Modeling System (WMS) software, Analysis of the morphometric information indicated that the morphometric ...
Al-Ansari, Nadhir, Dawood, Anwer H., Mawlood, Dana K.   +2 more
core   +2 more sources

Climatic impact on Rainfall Analysis in Al-Madinah Munawwara Region

IOP Conference Series: Earth and Environment, 2022
Long-term changes in temperature and weather patterns are referred to as climate change. Climate change and rainfall distribution are inextricably linked to arid and semi-arid regions. Saudi Arabia is entirely located in arid and semi-arid areas, and the
A. Aldrees
semanticscholar   +1 more source

A Combination between Synthetic Unit Hydrograph (SCS) and Rational Method in a similar Conditions Water Shed

Asian Journal of Engineering and Technology, 2021
Studying watershed characteristics and choosing the most applicable methods to determine the amount of access rainfall that ran off is very important in many engineering applications, especially hydrology applications.
Mona Fathi, Neveen B. Abelmageed, M. Hassan   +2 more
semanticscholar   +1 more source

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.

New England Journal of Medicine, 2022
BACKGROUND Neoadjuvant or adjuvant chemotherapy confers a modest benefit over surgery alone for resectable non-small-cell lung cancer (NSCLC). In early-phase trials, nivolumab-based neoadjuvant regimens have shown promising clinical activity; however ...
P. Forde, J. Spicer, Shun Lu, M. Provencio, T. Mitsudomi, M. Awad, E. Felip, S. Broderick, J. Brahmer, S. Swanson, K. Kerr, Changli Wang, T. Ciuleanu, G. Saylors, F. Tanaka, H. Ito, Keke Chen, M. Liberman, E. Vokes, J. Taube, C. Dorange, Junliang Cai, J. Fiore, A. Jarkowski, D. Balli, M. Sausen, D. Pandya, C. Calvet, N. Girard   +28 more
semanticscholar   +1 more source

Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.

New England Journal of Medicine, 2023
BACKGROUND Standard first-line chemotherapy for endometrial cancer is paclitaxel plus carboplatin. The benefit of adding pembrolizumab to chemotherapy remains unclear.
R. Eskander, M. Sill, L. Beffa, Richard G. Moore, J. Hope, Fernanda B. Musa, R. Mannel, M. Shahin, G. Cantuaria, E. Girda, C. Mathews, J. Kavecansky, Charles A Leath Iii, L. Gien, E. Hinchcliff, S. Lele, L. Landrum, F. Backes, R. O'Cearbhaill, T. Al baghdadi, E. Hill, P. Thaker, V. John, S. Welch, A. Fader, M. Powell, C. Aghajanian   +26 more
semanticscholar   +1 more source

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.

The Lancet Oncology, 2023
BACKGROUND Systemic therapies have improved the management of hepatocellular carcinoma, but there is still a need to further enhance overall survival in first-line advanced stages.
J. Llovet, Masatoshi Kudo, P. Merle, Tim Meyer, Shukui Qin, M. Ikeda, R. Xu, J. Edeline, B. Ryoo, Z. Ren, G. Masi, M. Kwiatkowski, H. Lim, Jeehyoung Kim, V. Breder, H. Kumada, A. Cheng, Peter R. Galle, S. Kaneko, Anran Wang, K. Mody, C. Dutcus, L. Dubrovsky, A. Siegel, R. Finn   +24 more
semanticscholar   +1 more source

Flood Risk Analysis in Potential Points, Zerin City in Erbil as a Case Study [PDF]

, 2023
The city of Erbil, the capital of the Kurdistan Region-Iraq, is exposed to frequent floods and cause human and material losses. The current research is analysis of floods as a case study on Zerin City, which was exposed to flood last session 2021-2022 ...
Anwer Dawood, Dana Mawlood
core   +2 more sources

Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma.

NEJM Evidence, 2022
Tremelimumab/Durvalumab for Hepatocellular CarcinomaThis trial examined overall survival (OS) with tremelimumab plus durvalumab, durvalumab alone, or sorafenib in untreated patients with hepatocellular cancer who were not candidates for locoregional ...
G. Abou-Alfa, G. Lau, M. Kudo, S. Chan, R. Kelley, J. Furuse, W. Sukeepaisarnjaroen, Yoon-Koo Kang, T. Van Dao, E. D. De Toni, L. Rimassa, V. Breder, Alexander Vasilyev, A. Heurgué, V. Tam, K. Mody, S. Thungappa, Y. Ostapenko, T. Yau, S. Azevedo, M. Varela, A. Cheng, S. Qin, P. Galle, Sajid Ali, M. Marcovitz, M. Makowsky, P. He, J. Kurland, A. Negro, B. Sangro   +30 more
semanticscholar   +1 more source

Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma.

Journal of Hepatology, 2021
BACKGROUND & AIMS IMbrave150 demonstrated significantly improved overall survival (OS) and progression-free survival (PFS) with atezolizumab plus bevacizumab vs sorafenib in patients with unresectable hepatocellular carcinoma at the primary analysis ...
A. Cheng, S. Qin, M. Ikeda, P. Galle, M. Ducreux, Tae-You Kim, Ho Yeong Lim, M. Kudo, V. Breder, P. Merle, A. Kaseb, Daneng Li, W. Verret, N. Ma, A. Nicholas, Yifan Wang, Lindong Li, A. Zhu, R. Finn   +18 more
semanticscholar   +1 more source

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.

New England Journal of Medicine, 2021
BACKGROUND Lenvatinib in combination with pembrolizumab or everolimus has activity against advanced renal cell carcinoma. The efficacy of these regimens as compared with that of sunitinib is unclear. METHODS In this phase 3 trial, we randomly assigned (
R. Motzer, B. Alekseev, S. Rha, C. Porta, M. Eto, T. Powles, V. Grünwald, Thomas E. Hutson, E. Kopyltsov, M. Méndez-Vidal, V. Kozlov, A. Alyasova, Sung-Hoo Hong, A. Kapoor, Teresa Alonso Gordoa, J. Merchan, E. Winquist, P. Maroto, J. Goh, Miso Kim, H. Gurney, V. Patel, A. Peer, G. Procopio, T. Takagi, B. Melichar, F. Rolland, U. de Giorgi, Shirley S. Wong, J. Bedke, M. Schmidinger, C. Dutcus, Alan D. Smith, L. Dutta, K. Mody, R. Perini, D. Xing, T. Choueiri   +37 more
semanticscholar   +1 more source